TY  - JOUR

T1  - Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.

JO  - Pharmacoeconomics

PY  - 2012/10/12

AU  - Whyte S

AU  - Pandor A

AU  - Stevenson M

ED  - 

DO  - DOI: 10.2165/11597210-000000000-00000

VL  - 30

IS  - 12

SP  - 1119

EP  - 1132

Y2  - 2024/12/22

ER  -